Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | FNTA | P49354 | 1/20 | 0.30 |
| ▸ | FNTB | P49356 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26472 | 1.00 | CD81 (0.37) | CD81PPARGPTGS1PDE4ALMNA | |
| Hydrochloric Acid SCHEMBL15637922 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| Ammonia Solution, Strong SCHEMBL5050827 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| SCHEMBL16318563 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| SCHEMBL11264760 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| SCHEMBL3174331 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| SCHEMBL16318562 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| SCHEMBL3174345 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| SCHEMBL9998853 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA | |
| Hydrochloric Acid SCHEMBL15637924 | 0.98 | CD81 (0.36) | CD81PPARGPTGS1PDE4ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1051 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705526-B1 | POLYMER TANNING AGENT | SNF GROUP (FR) | 2026-05-27 | — | — | EP | claimed |
| CN-114868298-B | Composite stripping method | Guangdong Haozhi Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12630703-B2 | High molecular weight anionic polyacrylamides | SNF GROUP (FR) | 2026-05-19 | — | — | US | claimed |
| US-20260117339-A1 | METHODS AND COMPOSITIONS FOR TREATING IRON ORES | ECOLAB USA INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4705526-A1 | POLYMER TANNING AGENT | SNF Group (FR) | 2026-03-11 | — | — | EP | claimed |
| US-12516235-B2 | Cementitious composition comprising a polymeric micro-gel as an anti-gas migration agent | SNF GROUP (FR) | 2026-01-06 | — | — | US | claimed |
| US-RE50703-E1 | Polymer composition | Mitsubishi Chemical UK Limited (GB) | 2025-12-16 | — | — | US | claimed |
| EP-3956411-B1 | SURFACE COATED ABRASIVE PARTICLES FOR TUNGSTEN BUFF APPLICATIONS | CMC MAT LLC (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4526256-B1 | VANADIUM OXIDE EXTRACTION FROM BAYER PROCESS | SNF GROUP (FR) | 2025-11-05 | — | — | EP | claimed |
| US-12365754-B2 | Polymer and method for the preparation thereof | SNF GROUP (FR) | 2025-07-22 | — | — | US | claimed |
| US-4652603-A | COPOLYMER OF VINYLIDENE CHLORIDE, A POLAR HYDROXYCOMONOMER AND A PLASTICIZING MONOMER CROSSLINKED WITH A DIALDEHYDE | UNION OIL COMPANY OF CALIFORNIA (US) | 1987-03-24 | — | — | US | claimed |
| US-4617321-A | Synthesis of highly cross-linked cation-exchange polymers from an aqueous solution | IONICS, INCORPORATED (US) | 1986-10-14 | — | — | US | claimed |
| US-4584339-A | TWO WATER SOLUBLE COPOLYMERS, ONE CONTAINING CATIONIC COMONOMERS, THE OTHER CONTAINING ANIONIC COMONOMERS | EXXON RESEARCH AND ENGINEERING CO. (US) | 1986-04-22 | — | — | US | claimed |
| US-4544699-A | Composition for improved adhesion of vinylidene chloride latex to ionomer films | UNION OIL COMPANY OF CALIFORNIA (US) | 1985-10-01 | — | — | US | claimed |
| US-4536539-A | Dilatant behavior of interpolymer complexes in aqueous solution | EXXON RESEARCH AND ENGINEERING CO. (US) | 1985-08-20 | — | — | US | claimed |
| US-4489180-A | ANIONIC AND CATIONIC COPOLYMERS | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-12-18 | — | — | US | claimed |
| EP-0021019-B1 | PHOTOCROSSLINKABLE COPOLYMERS, PHOTOSENSITIVE RECORDING MATERIAL CONTAINING THEM, ITS UTILISATION IN THE PRODUCTION OF PHOTOGRAPHIC PICTURES AND PROCESS FOR THE PRODUCTION OF PHOTOGRAPHIC PICTURES | CIBA-GEIGY AG (CH) | 1984-10-17 | — | — | EP | claimed |
| EP-0021019-A1 | Photocrosslinkable copolymers, photosensitive recording material containing them, its utilisation in the production of photographic pictures and process for the production of photographic pictures | CIBA-GEIGY AG (CH) | 1981-01-07 | — | — | EP | claimed |
| US-4174152-A | Electrochromic devices with polymeric electrolytes | AMERICAN CYANAMID COMPANY (US) | 1979-11-13 | — | — | US | claimed |
| US-4075134-A | EMULSION POLYMERIZATION METHOD FOR PREPARING MICROSPHERES HAVING LIQUID CENTER AND SEAMLESS RIGID WALLS | THE DOW CHEMICAL COMPANY (US) | 1978-02-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117339-A1 | METHODS AND COMPOSITIONS FOR TREATING IRON ORES | SFXN3, SLC11A2, SFXN1 | CD81 1379/4885PPARG 2164/4885PTGS1 4571/4885 |
| US-12630703-B2 | High molecular weight anionic polyacrylamides | ACP1, PDAP1, P2RY11 | CD81 869/4885PPARG 1933/4885PTGS1 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.